February 24, 2021 Comments Off on New patent for Biocryst drug RAPIVAB Posted in: Patent Added Annual Drug Patent Expirations for RAPIVAB Rapivab is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Biocryst drug RAPIVAB appeared first on DrugPat…
February 24, 2021 Comments Off on New patent for Biocryst drug RAPIVAB Posted in: Patent Added Annual Drug Patent Expirations for RAPIVAB Rapivab is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Biocryst drug RAPIVAB appeared first on DrugPat…
